Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions AnaptysBio, Inc.

Equities

ANAB

US0327241065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
23.91 USD -4.21% Intraday chart for AnaptysBio, Inc. -4.63% +11.62%
May. 09 AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 09 Anaptys Announces Positive Top-Line Gemini-2 Phase 3 Clinical Trial Results of imsidolimab (IL-36R) in Generalized Pustular Psoriasis CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Revisions AnaptysBio, Inc.